![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
The 5th Global College of Neuroprotection and Neuroregeneration (GCNN) was held in the historic charming capital city of Bucharest, Romania in JW Marriott Grand Hotel on 3–6 March, 2008. The meeting was a unique blend of basic researchers and clinicians across the Globe presenting their recent findings in neuroprotection and neuroregeneration in a beautiful exotic ambience. More than 300 students and researchers attended the congress and participated in deliberations. Over 60 representatives from various pharmaceutical industries from all over the world supported this event. This meeting was held for the first time as a joint venture with GCNN and the Society for study on Neuroproetction and Neuroplasticity (SSNN), and was a grand success both scientifically and socially. Thus, these joint meetings of the two societies (GCNN and SSNN) will continue in future in different European cities for the coming 5 years.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
The author’s research on nanoparticles is partly supported by European Office of Aerospace Research and Development (EOARD), US Air Force, London Office, UK; Astra Zeneca, Mölndal, Sweden, Uppsala University, Uppsala, Sweden, Global College of neuroprotection and Neuroregeneration (GCNN), UK, Ebewe Pharma, Austria, and Society for Study on Neuroprotection and Neuroplasticity (SSNN, Cluj, Romania). However, the author has no conflict of interest with any organization or the pharmaceutical companies listed above for his research or his association with Uppsala University.
The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Disclosure
The views expressed in this report are exclusively the author’s own opinion based on current scientific literature and available knowledge so far. These views in no way represent the official opinion of any organization mentioned above or Uppsala University.